Conjunctival langerhans cell histiocytosis: a case report.
- Author:
Di CHEN
1
;
Han-Yi MIN
1
Author Information
1. Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
- Publication Type:Journal Article
- MeSH:
Conjunctival Diseases;
diagnosis;
drug therapy;
Cyclophosphamide;
therapeutic use;
Cyclosporine;
therapeutic use;
Female;
Histiocytosis, Langerhans-Cell;
diagnosis;
drug therapy;
Humans;
Middle Aged;
Prednisone;
therapeutic use
- From:
Chinese Medical Sciences Journal
2015;30(1):63-64
- CountryChina
- Language:English
-
Abstract:
Langerhans cell histiocytosis (LCH) is a rare disease, mainly involving the bone, skin, lung, liver, spleen, and skin.1 The heterogenenous nature of LCH makes it difficult to diagnose. Not only do the involved organs vary from case to case, but also its natural history. Herein, we describe a rare case of conjuctival LCH in an Asian woman.
